CDH11 and pancreatic neoplasm: However, the Cdh11 inhibitor, was ineffective in reducing tumor burden of mT3 pancreatic tumor bearing immunosuppressed Rag1-mutant mice, suggesting that T and B cells are required for immunomodulation of PDAC mediated by Cdh11 inhibition (23).